6 days ago1 min readThe market for ‘gene silencing’ therapies is set to explode Dan Williams discusses the reasons behind this in FirstWord Pharma. Read his analysis here.
Amy Sheridan-Hill, co-founder of the H-ABC Foundation, and Dan Williams in major Mirror story about hopes for new drug
SynaptixBio’s collaboration with leading global drug researcher Evotec featured in European Biotechnology Magazine
Dan Williams and Amy Sheridan-Hill, whose son Frankie suffers from H-ABC, interviewed for the Evening Standard.
Commentaires